Vig Pamela
- SEC CIK
- 0001780069
No open-market purchases or sales filed in the past year.
Current role at each company
- MIRM Mirum Pharmaceuticals, Inc.CHIEF SCIENTIFIC OFFICERas of Jun 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vig Pamela as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2024 (view filing) | Jun 24 | 1 day | Vig PamelaCHIEF SCIENTIFIC OFFICER | SSale | −30.6K | $34.00 | −$1.04M | −52.7%27.4K after | 10b5-1 |
| Mar 18, 2024 (view filing) | Jan 9, 2023 | 434 daysLate | Vig PamelaCHIEF SCIENTIFIC OFFICER | SSale | −1.38K | $20.62 | −$28.4K | −4.8%27.3K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Vig PamelaCHIEF SCIENTIFIC OFFICER | SSale | −1.21K | $26.19 | −$31.8K | −4.1%28.7K after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Vig PamelaHEAD OF RESEARCH & DEVELOPMENT | SSale | −1.41K | $28.03 | −$39.5K | −4.5%29.9K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Vig PamelaHead of Research & Development | SSale | −1.43K | $25.65 | −$36.6K | −4.4%30.8K after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Vig PamelaChief Scientific Officer | SSale | −1.36K | $19.26 | −$26.3K | −12.4%9.67K after |